0QLR.L vs. ^SSMI

Last updated Jun 5, 2026

0QLR.L (Novartis AG) is a stock, while ^SSMI (Swiss Market Index) is an index. Over the past 5 years, 0QLR.L returned 8.64%/yr vs 6.74%/yr for ^SSMI. At a 0.42 correlation, their price movements are largely independent.

Performance

0QLR.L vs. ^SSMI - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Novartis AG (0QLR.L) and Swiss Market Index (^SSMI). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

0QLR.L is traded in GBP, while ^SSMI is traded in CHF. To make them comparable, the ^SSMI values have been converted to GBP using the latest available exchange rates.

Returns By Period

In the year-to-date period, 0QLR.L achieves a 5.61% return, which is significantly higher than ^SSMI's 1.23% return.

0QLR.L

• 1D: 2.16%
• 1M: 0.37%
• YTD: 5.61%
• 6M: 8.10%
• 1Y: 19.72%
• 3Y*: 10.30%
• 5Y*: 8.64%
• 10Y*: —

^SSMI

• 1D: 1.26%
• 1M: 0.33%
• YTD: 1.23%
• 6M: 4.41%
• 1Y: 13.92%
• 3Y*: 7.52%
• 5Y*: 6.74%
• 10Y*: 8.02%

*Multi-year figures are annualized to reflect compound growth (CAGR)

0QLR.L vs. ^SSMI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
0QLR.L Novartis AG	5.61%	23.74%	4.99%	5.58%	4.77%	4.00%
^SSMI Swiss Market Index	1.23%	21.67%	-1.63%	8.32%	-8.07%	26.65%

Correlation

The correlation between 0QLR.L and ^SSMI is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.43
Correlation (3Y) Calculated over the trailing 3-year period	0.42
Correlation (5Y) Calculated over the trailing 5-year period	0.42
Correlation (All Time) Calculated using the full available price history since Mar 8, 2021	0.42

Return for Risk

0QLR.L vs. ^SSMI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

0QLR.L

0QLR.L Risk / Return Rank: 71
0QLR.L Sharpe Ratio Rank: 75
0QLR.L Sortino Ratio Rank: 70
0QLR.L Omega Ratio Rank: 69
0QLR.L Calmar Ratio Rank: 69
0QLR.L Martin Ratio Rank: 70

^SSMI

^SSMI Risk / Return Rank: 35
^SSMI Sharpe Ratio Rank: 36
^SSMI Sortino Ratio Rank: 35
^SSMI Omega Ratio Rank: 37
^SSMI Calmar Ratio Rank: 32
^SSMI Martin Ratio Rank: 34

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

0QLR.L vs. ^SSMI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (0QLR.L) and Swiss Market Index (^SSMI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	0QLR.L	^SSMI	Difference
Sharpe ratio: Return per unit of total volatility	1.17	1.07	+0.10
Sortino ratio: Return per unit of downside risk	1.74	1.54	+0.20
Omega ratio: Gain probability vs. loss probability	1.22	1.20	+0.02
Calmar ratio: Return relative to maximum drawdown	1.54	1.05	+0.49
Martin ratio: Return relative to average drawdown	3.70	3.14	+0.55
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

0QLR.L vs. ^SSMI - Sharpe Ratio Comparison

The current 0QLR.L Sharpe Ratio is 1.17, which is comparable to the ^SSMI Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of 0QLR.L and ^SSMI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	0QLR.L	^SSMI	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.17	1.07	+0.10
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.49	0.48	+0.01
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.54	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.53	0.40	+0.13

Drawdowns

0QLR.L vs. ^SSMI - Drawdown Comparison

The maximum 0QLR.L drawdown since its inception was -18.04%, smaller than the maximum ^SSMI drawdown of -31.57%. Use the drawdown chart below to compare losses from any high point for 0QLR.L and ^SSMI.

Drawdown Indicators

	0QLR.L	^SSMI	Difference
Max Drawdown Largest peak-to-trough decline	-18.04%	-31.57%	+13.53%
Max Drawdown (1Y) Largest decline over 1 year	-13.38%	-13.28%	-0.10%
Max Drawdown (3Y) Largest decline over 3 years	-18.04%	-14.48%	-3.56%
Max Drawdown (5Y) Largest decline over 5 years	-18.04%	-16.66%	-1.38%
Max Drawdown (10Y) Largest decline over 10 years	—	-21.58%	—
Current Drawdown Current decline from peak	-11.45%	-6.84%	-4.61%
Average Drawdown Average peak-to-trough decline	-5.51%	-6.09%	+0.58%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.55%	4.41%	+1.14%

Volatility

0QLR.L vs. ^SSMI - Volatility Comparison

Novartis AG (0QLR.L) has a higher volatility of 5.41% compared to Swiss Market Index (^SSMI) at 4.26%. This indicates that 0QLR.L's price experiences larger fluctuations and is considered to be riskier than ^SSMI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	0QLR.L	^SSMI	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.41%	4.26%	+1.15%
Volatility (6M) Calculated over the trailing 6-month period	12.64%	10.65%	+1.99%
Volatility (1Y) Calculated over the trailing 1-year period	17.73%	13.13%	+4.60%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.78%	14.14%	+3.64%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.52%	14.87%	+2.65%

Frequently Asked Questions

Can I hold both 0QLR.L and ^SSMI in my portfolio?

0QLR.L and ^SSMI have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.